EMA announces GMP violations: India and China are the top drug companies
-
Last Update: 2014-01-23
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Pharma online 2014-1-23 in order to increase transparency, the European Drug Administration (EMA) has published the eudragmdp database, which collates factories that do not conform to GMP The database organizes and publishes manufacturing, import and wholesale distribution authorization, GMP, GDP certificates and those that do not meet GMP requirements In a statement, EMA said the new measure had been adopted as a way to improve transparency and business development Currently, the database includes more than 80 violations since 2007 According to the report, 34 facilities failed to comply with GMP in 2013, which affected the production of sterile, non sterile and API These problems also include quality control testing, packaging and product production In 2013, 10 manufacturing plants failed to comply with GMP in China and 14 in India
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
